Health ❯Healthcare

Medications

Weight Loss Weight Loss Drugs GLP-1 Drugs Side Effects Weight Loss Medications Diabetes Diabetes Medications Weight Management Weight-loss Drugs GLP-1 Agonists

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials

Lowering cerebrospinal fluid pressure produced significant migraine relief without affecting weight in the initial trial.

Senator Maggie Hassan Launches Probe of GSK’s Pediatric Asthma Inhaler Switch

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Liraglutide Cuts Chronic Migraine Days by More Than Half

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

MHRA Warns Women on Ozempic, Mounjaro and Wegovy to Use Effective Contraception After Pregnancy Reports

Gemma Collins Battles Three-Week Pneumonia with Home IV Treatment

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Biannual Zilebesiran Injections Significantly Lower Blood Pressure in Resistant Hypertension

Three Arrested After Unlicensed Weight-Loss Jab Leaves Woman Hospitalized

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Study Confirms Triptan Use in Pregnancy Does Not Increase Neurodevelopmental Risks

Cardiologist Follow-Up Found to Halve Mortality Risk in Heart Failure Patients

Paramedic Pleads Guilty to Secretly Administering Abortion Drug to Pregnant Woman

Study Links Medicaid Disenrollment to Increased Mortality Among Low-Income Seniors

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

New Analysis Suggests Ubrogepant May Ease Early Migraine Symptoms

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health